Partners
Our partnering strategy
Firebrick Pharma intends to expand the sales of Nasodine and our other products worldwide. Outside Australia, we are seeking international partners with the capabilities to support the registration and marketing of Nasodine in specific countries or regions.
We already have partners in place in several territories and they are all leaders in their fields with strong regulatory, distribution and marketing capabilities.
We will be actively seeking other international partners after we complete the second Phase 3 clinical trial of Nasodine for the treatment of the common cold. For all partnership enquiries please contact us.
Our partners
Who we work with
DOUGLAS PHARMACEUTICALS
New Zealand
Douglas Pharmaceuticals is New Zealand's largest privately owned pharmaceutical company with an ever-expanding footprint into global markets. Douglas Pharma has a relentless focus on making a positive difference in healthcare outcomes for people across the globe. Working with innovative partners to research & develop, manufacture, market and distribute prescription and over-the-counter pharmaceutical, nutraceutical, automated compliance systems and consumer healthcare products.
SV MORE PHARMACEUTICALS
Philippines
S.V. More Group of Companies is a 100% Filipino-owned pharmaceutical marketing firm with over 30 years of unwavering commitment to provide high quality, cost effective, and reliable health products that every Filipino family deserves. S.V. More Group with its 3 parent companies and 7 distributing companies, has operations spanning the entire Philippine Archipelago to ensure that reliable and value-driven health products are within reach of all Filipinos.
ADCOCK INGRAM
South Africa & Sub Saharan African countries
Adcock Ingram is a leading South African pharmaceutical manufacturer listed on the Johannesburg Stock Exchange. Adcock Ingram is ranked as the second largest manufacturer in the private pharmaceutical market and is the second largest supplier to the public sector in South Africa and several countries in sub–Saharan Africa. Of note is the major share of the critical care market held by the company, being the largest supplier of critical care products to the public sector and hospitals. The business is a fully integrated operation which spans regulatory, manufacturing, marketing, sales and distribution.